Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kalra

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
Cancer Treatment Reports|March 1, 1987
Pharmacokinetic comparison of intranasal, oral, and intramuscular metoclopramide in healthy volunteersM L Citron, J R Reynolds, J Kalra, et al.
Oncogene|September 15, 2010
Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1J Kalra, B W Sutherland, A L Stratford, et al.
The Journal of Pathology|May 1, 1991
Late BCNU lung: a light and ultrastructural study on the delayed effect of BCNU on the lung parenchymaP S Hasleton, B R O'Driscoll, P Lynch, et al.
Cancer|October 15, 1991
Cytosine arabinoside and cisplatin for advanced breast cancer. A phase II study of the Cancer and Leukemia Group BM W Oster, R L Schilsky, D Faraggi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1995
Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642)M E Costanza, D Berry, I C Henderson, et al.
Cancer|April 15, 1981
Chemotherapy for head and neck cancer relapsing after radiotherapyE P Cortes, J Kalra, V C Amin, et al.
The World Journal of Men'S Health|April 7, 2026
Safety of Testosterone Therapy in Chronic Kidney Disease: A Propensity Score-Matched Cohort StudyLino Merlino, Francesco Rainone, James Tollitt, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 4, 2015
Determination of an optimal dosing schedule for combining Irinophore C™ and temozolomide in an orthotopic model of glioblastomaM Verreault, M Wehbe, D Strutt, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Cancer Treatment Reports|March 1, 1987
Pharmacokinetic comparison of intranasal, oral, and intramuscular metoclopramide in healthy volunteersM L Citron, J R Reynolds, J Kalra, et al.
Oncogene|September 15, 2010
Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1J Kalra, B W Sutherland, A L Stratford, et al.
The Journal of Pathology|May 1, 1991
Late BCNU lung: a light and ultrastructural study on the delayed effect of BCNU on the lung parenchymaP S Hasleton, B R O'Driscoll, P Lynch, et al.
Cancer|October 15, 1991
Cytosine arabinoside and cisplatin for advanced breast cancer. A phase II study of the Cancer and Leukemia Group BM W Oster, R L Schilsky, D Faraggi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1995
Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642)M E Costanza, D Berry, I C Henderson, et al.
Cancer|April 15, 1981
Chemotherapy for head and neck cancer relapsing after radiotherapyE P Cortes, J Kalra, V C Amin, et al.
The World Journal of Men'S Health|April 7, 2026
Safety of Testosterone Therapy in Chronic Kidney Disease: A Propensity Score-Matched Cohort StudyLino Merlino, Francesco Rainone, James Tollitt, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 4, 2015
Determination of an optimal dosing schedule for combining Irinophore C™ and temozolomide in an orthotopic model of glioblastomaM Verreault, M Wehbe, D Strutt, et al.
Pageof 10